Baylor College of Medicine will work with Chinese firm Berry Genomics to enhance the way prenatal genetic testing is performed. The partnership will allow BCM to combine its gene-chip microarray tools, which are used to analyze chromosome structure, with Berry Genomics' systems for assessing fetal DNA derived from maternal plasma.